Results 11 to 20 of about 8,456 (172)

Recurrent Steroid-Responsive Exophthalmos as a Paraneoplastic Manifestation of Esophageal Adenocarcinoma. [PDF]

Case Rep Oncol Med
Exophthalmos is most often associated with autoimmune thyroid disease, particularly Graves disease. Paraneoplastic syndromes rarely manifest as orbital inflammation, and only a few cases have been described in association with solid tumors. We present a case of a 67‐year‐old male diagnosed with esophageal cancer.
Tovar YE, Elsayed AG.
europepmc   +2 more sources

Seminoma-associated orbitopathy mimicking thyroid-associated orbitopathy : report of a case and literature review

, 2023
The authors describe a case of bilateral diffuse paraneoplastic orbital myositis induced by a stage IA left testicular pure seminoma. The patient presented with findings typical of thyroid-associated orbitopathy (TAO) and was thought to have TAO until ...
Bernard, Léa, Tobalem, Stéphan Jonathan, Jakubowska, Weronika, Toupin, Francis, Kalin-Hajdu, Evan   +4 more
core   +1 more source

Selenium and the course of mild Graves' orbitopathy

, 2011
Background Oxygen free radicals and cytokines play a pathogenic role in Graves' orbitopathy. Methods We carried out a randomized, double-blind, placebo-controlled trial to determine the effect of selenium (an antioxidant agent) or pentoxifylline (an ...
Altea M. A., Prummel M. D., BENCIVELLI, VALTER, Mourits MP, Nardi M., Kahaly GJ, Boboridis K., Pitz S, Altea MA, NARDI, MARCO, Prummel M, Krassas G. E., Kahaly G. J., Stahl M., von Arx G., von Arx G, European Group on Graves' Orbitopathy, MARCOCCI, CLAUDIO, Wiersinga W, Boboridis K, Mpourits M. P., Pitz S., Bencivelli W., Baldeschi L., BARTALENA, LUIGI, BALDESCHI, LELIO, Bartalena L, Stahl M, Sivelli P., Krassas GE, Wiersinga W. for the European Group on Graves' Orbitopathy, Sivelli P, Marcocci C.   +32 more
core   +2 more sources

Surgical treatment of thyroid orbitopathy

, 2023
Thyroid Orbitopathy is manifestation of Grave’s Disease that affects eyes and orbital area. It occurs in the active and inactive phase, during which different signs are presented. When Thyroid Orbitopathy reaches its advanced phase it should be operated,
Zabochnicki, Mateusz, Pojda-Wilczek, Dorota, Szaraniec, Wojciech   +2 more
core   +1 more source

Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy [PDF]

, 2012
BACKGROUND: Optimal doses of i.v. glucocorticoids for Graves' orbitopathy (GO) are undefined. METHODS: We carried out a multicenter, randomized, double-blind trial to determine efficacy and safety of three doses of i.v. methylprednisolone in 159 patients
Bernard M, for the European Group on Graves' Orbitopathy, Soeters, M R, Daumerie, C., Currò N, Nardi, M, Mourits, M P, Salvi M, Stahl, M., Boboridis KG, Nardi, M., Bernard, M., Stahl, M, Daumerie C, Baldeschi, L., Azzolini, C, Wiersinga, W., Sassi, L, Boschi A, MARCOCCI, CLAUDIO, Currò, N, Wiersinga W, von Arx, G, Boschi, A., Bournaud C, Boboridis, K G, Veronesi, G., Stahl M, Bartalena L, BALDESCHI, LELIO, Veronesi, G, Baldeschi, L, Bournaud, C., Mourits, M. P., Krassas GE, Sassi, L., Salvi, M., Currò, N., Krassas G, Baldeschi L, Veronesi G, Boschi, Antonella, VERONESI, GIOVANNI, Marcocci, C, SASSI, LORENZA, Azzolini C, Azzolini, C., von Arx, G., Mourits MP, Nardi M, Wiersinga, W, AZZOLINI, CLAUDIO, NARDI, MARCO, Bernard, M, for the European Group on Graves Orbitopathy, Boboridis, K. G., von Arx G, European Group on Graves' Orbitopathy, Marcocci C, Krassas, G. E., Daumerie, Chantal, Wiersinga WM, Soeters, M. R., Marcocci, C., BARTALENA, LUIGI, Bournaud, C, Salvi, M, Soeters MR, Sassi L, Curr? N, Bartalena, L., Krassas, G E, Bartalena, L   +72 more
core   +1 more source

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis

, 2017
Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients.
Nur Kebapçı, Nilgün Yıldırım, Belgin Efe, Tülay Şimşek   +3 more
core   +1 more source

Thyroid Orbitopathy and Dry Eye

, 2011
Thyroid orbitopathy (TO) is an inflammatory autoimmune disease of the orbital and periorbital tissues that is characterized by the presence of autoantibodies against thyroid-stimulating hormone receptor (TSH-R).
Canan Gürdal, Özge Saraç
core   +1 more source

Late recurrence of unilateral graves orbitopathy on the contralateral side

, 2002
PURPOSE: To report a case of late recurrence of unilateral Graves orbitopathy on the contralateral side after 7 years. DESIGN: Interventional case report.
Mourits, Maarten P., Maarten P. Mourits, Rachel Kalmann, Kalmann, Rachel   +3 more
core   +2 more sources

The role of pain in Graves' orbitopathy: Associations with clinical activity and quality of life

Acta Ophthalmologica, EarlyView.
Abstract Purpose Pain is included in the clinical activity score (CAS) as an indicator of inflammatory activity in Graves' orbitopathy (GO), yet its clinical relevance has not been systematically evaluated. We therefore investigated the relationship between pain, other inflammatory signs and quality of life (QoL), and assessed the effect of intravenous
Gijsbert J. Hötte, Willem A. Dik, Ronald O. B. de Keizer, Sodaba Khatab, Marco Medici, Maaike de Bie, P. Martin van Hagen, Dion Paridaens   +7 more
wiley   +1 more source

IgG4‐Related Disease Overlapping With Anti‐Acetylcholine Receptor Antibody–Positive Myasthenia Gravis

Clinical and Experimental Neuroimmunology, Volume 17, Issue 3, August 2026.
ABSTRACT Background IgG4‐related disease (IgG4‐RD) is a systemic, immune‐mediated, fibroinflammatory disorder with multiorgan involvement and variable clinical presentation, often creating diagnostic difficulty. Myasthenia gravis (MG) is an antibody‐mediated autoimmune disorder of the neuromuscular junction, most commonly associated with anti ...
Yumiko Yoshida, Ayami Okuzumi, Yuka Hosaka, Yuji Tomizawa, Taku Hatano   +4 more
wiley   +1 more source